Nuvectis Pharma Inc

Stock Chart, Company Information, and Scan Results

$20.53(as of Sep 29, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Nuvectis Pharma Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$20.53
Ticker SymbolNVCT
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees16
CountyUSA
Market Cap$660.1M
EBIDTA0.0M
10-Day Moving Average21.45
P/E Ratio0.00
20-Day Moving Average22.44
Forward P/E Ratio0.00
50-Day Moving Average21.65
Earnings per Share-1.32
200-Day Moving Average13.27
Profit Margin0.00%
RSI43.07
Shares Outstanding32.6M
ATR1.57
52-Week High29.28
Volume160,030
52-Week Low5.55
Most Recent Support Level19.55
Book Value0.0M
Most Recent Resistance Level23.18
P/B Ratio0.00
Upper Keltner25.98
P/S Ratio0.00
Lower Keltner18.90
Debt-to-Equity Ratio0.00
Next Earnings Date11/03/2026
Cash Surplus0.0M
Next Ex-Dividend DateUnknown

Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NXP900, a small molecule drug candidate, which is in Phase 1b clinical trial that inhibits the proto-oncogene c-Src and YES1 kinases for treating solid tumors. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.

Nuvectis Pharma Inc In Our Stock Scanner

As of Sep 29, 2026
example chart graphic
Scan Name: Undervalued Blue ChipsScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Double BottomScan Type: Chart Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.